Humacyte Stock Technical Analysis
| HUMA Stock | USD 0.96 0.04 4.00% |
As of the 4th of February, Humacyte retains the Standard Deviation of 4.76, risk adjusted performance of (0.1), and Market Risk Adjusted Performance of (0.30). Humacyte technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Humacyte Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Humacyte, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to HumacyteHumacyte's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Humacyte Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 7.71 | Strong Buy | 7 | Odds |
Most Humacyte analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Humacyte stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Humacyte, talking to its executives and customers, or listening to Humacyte conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Humacyte. Market participants price Humacyte higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Humacyte assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.27) | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets | Return On Equity |
Humacyte's market price often diverges from its book value, the accounting figure shown on Humacyte's balance sheet. Smart investors calculate Humacyte's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Humacyte's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Humacyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Humacyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Humacyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Humacyte 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Humacyte's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Humacyte.
| 11/06/2025 |
| 02/04/2026 |
If you would invest 0.00 in Humacyte on November 6, 2025 and sell it all today you would earn a total of 0.00 from holding Humacyte or generate 0.0% return on investment in Humacyte over 90 days. Humacyte is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Apollomics, Ainos, OSR Holdings, and Lipocine. Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues... More
Humacyte Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Humacyte's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Humacyte upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 20.54 | |||
| Value At Risk | (8.13) | |||
| Potential Upside | 8.16 |
Humacyte Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Humacyte's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Humacyte's standard deviation. In reality, there are many statistical measures that can use Humacyte historical prices to predict the future Humacyte's volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (1.04) | |||
| Treynor Ratio | (0.31) |
Humacyte February 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.1) | |||
| Market Risk Adjusted Performance | (0.30) | |||
| Mean Deviation | 3.75 | |||
| Coefficient Of Variation | (701.13) | |||
| Standard Deviation | 4.76 | |||
| Variance | 22.66 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (1.04) | |||
| Treynor Ratio | (0.31) | |||
| Maximum Drawdown | 20.54 | |||
| Value At Risk | (8.13) | |||
| Potential Upside | 8.16 | |||
| Skewness | 0.6022 | |||
| Kurtosis | 0.7899 |
Humacyte Backtested Returns
Humacyte holds Efficiency (Sharpe) Ratio of -0.0864, which attests that the entity had a -0.0864 % return per unit of risk over the last 3 months. Humacyte exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Humacyte's Risk Adjusted Performance of (0.1), market risk adjusted performance of (0.30), and Standard Deviation of 4.76 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 2.24, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Humacyte will likely underperform. At this point, Humacyte has a negative expected return of -0.4%. Please make sure to check out Humacyte's maximum drawdown, daily balance of power, relative strength index, as well as the relationship between the skewness and day typical price , to decide if Humacyte performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.28 |
Poor predictability
Humacyte has poor predictability. Overlapping area represents the amount of predictability between Humacyte time series from 6th of November 2025 to 21st of December 2025 and 21st of December 2025 to 4th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Humacyte price movement. The serial correlation of 0.28 indicates that nearly 28.0% of current Humacyte price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.28 | |
| Spearman Rank Test | 0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Humacyte technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Humacyte Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Humacyte volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Humacyte Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Humacyte on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Humacyte based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Humacyte price pattern first instead of the macroeconomic environment surrounding Humacyte. By analyzing Humacyte's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Humacyte's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Humacyte specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Current Ratio | 4.52 | 2.4 | 2.76 | 2.62 | Net Debt To EBITDA | 0.24 | 0.21 | 0.25 | 0.23 |
Humacyte February 4, 2026 Technical Indicators
Most technical analysis of Humacyte help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Humacyte from various momentum indicators to cycle indicators. When you analyze Humacyte charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.1) | |||
| Market Risk Adjusted Performance | (0.30) | |||
| Mean Deviation | 3.75 | |||
| Coefficient Of Variation | (701.13) | |||
| Standard Deviation | 4.76 | |||
| Variance | 22.66 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (1.04) | |||
| Treynor Ratio | (0.31) | |||
| Maximum Drawdown | 20.54 | |||
| Value At Risk | (8.13) | |||
| Potential Upside | 8.16 | |||
| Skewness | 0.6022 | |||
| Kurtosis | 0.7899 |
Humacyte February 4, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Humacyte stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 237,062 | ||
| Daily Balance Of Power | (0.57) | ||
| Rate Of Daily Change | 0.96 | ||
| Day Median Price | 0.97 | ||
| Day Typical Price | 0.96 | ||
| Price Action Indicator | (0.03) |
Complementary Tools for Humacyte Stock analysis
When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |